Denali Advisors’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-45,500
Closed -$129K 375
2024
Q1
$129K Buy
+45,500
New +$155K 0.04% 260

Other funds holding ORGO

Denali Advisors's ORGO Position: Q2 2024 in Review

Denali Advisors sold out of Organogenesis Holdings (ORGO) in Q2 2024, closing a stake of 45,500 shares — an estimated $129K sold.

Denali Advisors first reported a position in ORGO in Q1 2024 and held it in 1 quarter. The position peaked at $129K in Q1 2024. 115 funds tracked by Wall St. Rank hold ORGO as of Q2 2024.

  • Denali Advisors reported no remaining Organogenesis Holdings position as of Q2 2024 after selling out during the quarter.
  • Denali Advisors sold 45,500 Organogenesis Holdings shares in Q2 2024, an estimated $129K.
  • Denali Advisors first reported a position in Organogenesis Holdings in Q1 2024 and held it in 1 quarter.
  • Denali Advisors's Organogenesis Holdings position peaked at $129K in Q1 2024.
  • 115 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2024.

Based on Denali Advisors's 13F filing for Q2 2024, filed 9 Aug 2024.